Contents
pdf Download PDF pdf Download XML
582 Views
630 Downloads
Share this article
Research Article | Volume 4 Issue 3 (None, 2010) | Pages 44 - 46
Multiple eruptive periungual pyogenic granulomas during anti-CD20 monoclonal antibody therapy for rheumatoid arthritis
Under a Creative Commons license
Open Access
PMID : PMC3157817
Received
Nov. 6, 2010
Published
Dec. 19, 2010
Abstract

Background:New targeted therapies have been developed for inflammatory and neoplastic diseases.Main observation:We report on a 73-year-old woman who developed multiple eruptive periungual and subungual pyogenic granulomas. Because of severe rheumatoid arthritis the patient was treated with monoclonal anti-CD20 antibodies. Eruptive granuloma pyogenicum developed after the second antibody application and remained more than 8 weeks after targeted therapy was over. New lesions, however, did not appear.Conclusion:Eruptive granuloma pyogenicum of the nail apparatus is a possible new rare adverse effect of targeted therapies. To the best of our knowledge this is the first case in association with anti-CD20 antibody treatment.

Keywords
Recommended Articles
Research Article
Successful Management of Severe Pediatric Annular Psoriasis with Targeted IL-17 Inhibition using Ixekizumab: A Case Report
...
Published: 20/11/2026
Research Article
A study on incidence and prognosis of Hyponatremia among patients admitted in High dependency respiratory care unit
Published: 08/01/2022
Research Article
Metabolic Syndrome Among Patients with Chronic Obstructive Pulmonary Disease: A prospective observational Study
Published: 24/06/2022
Research Article
A recurrent ulcer over the left thigh: The Diagnostic Mimicry between lupus profundus and non-uremic calciphylaxis
...
Published: 26/10/2026
© Copyright Spejalisci Dermatolodzy